IP Library › Granted Patent US 11,123,288
Granted Patent B2
US 11,123,288 · App. 16/436,695 · Granted Sep 21, 2021

Emulsion

Inventors: Ingvild Haug (Trondheim, NO); Kurt Ingar Draget (Trondheim, NO)
Assignee: VITUX GROUP AS
A61K9/0056A23G4/066A23L29/281A23L33/115A61K9/107A61K31/167A61K47/26A61K47/36A61K47/42A61K47/44B65D75/327A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,123,288
App. No.
16/436,695
Granted
Sep 21, 2021
Kind
B2
Abstract

The invention relates to an orally administrable chewable composition in unit dosage form comprising an oil-in-water emulsion in which the aqueous phase is gelled and in which the oil phase comprises a physiologically tolerable unsaturated fatty acid ester.

Claims (15)

1. An orally administrable chewable composition in unit dosage form comprising a chewable, set oil-in-water emulsion in which the aqueous phase is gelled, wherein said aqueous phase comprises gelatin in an amount of about 10% to 25% wt. of the aqueous phase and in which the oil phase comprises a physiologically tolerable omega-3 or omega-6 fatty acid ester and constitutes 5 to 75% wt. of the dose unit, and wherein the unit dosage form has an overall dose unit weight of 0.25 to 3 g and wherein the composition, upon chewing, remains free of bad odor and taste.

2. The composition as claimed in claim 1 wherein the fatty acid ester is a physiologically tolerable triglyceride.

3. The composition as claimed in claim 1 wherein the fatty acid ester is a fish oil.

4. The composition as claimed in claim 1 wherein said aqueous phase further comprises polysaccharides.

5. The composition as claimed in claim 1 wherein said aqueous phase further comprises carageenan.

6. The composition as claimed in claim 1 further comprising at least 1% wt. xylitol.

7. The composition as claimed in claim 1 further comprising a citrus flavor.

8. The composition as claimed in claim 1 wherein said aqueous phase comprises a water soluble vitamin.

9. The composition as claimed in claim 1 in an animal, a doll, a vehicle, a rod, a strip or a tube shape.

10. A package comprising an air-tight compartment containing one dose unit of a composition as claimed in claim 1 .

11. The package as claimed in claim 10 in the form of a blister pack.

12. A method of treatment of a human by oral administration of an effective amount of an active agent in oil form or dissolved in an oil comprising administering said active agent in a chewable composition according to claim 1 .

13. The method as claimed in claim 12 wherein said active agent is an analgesic.

14. The method as claimed in claim 12 wherein said active agent is a triglyceride.

15. The composition as claimed in claim 1 , wherein the oil phase constitutes 5 to 50% wt. of the dose unit.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2021
From: HAUG, INGVILD; DRAGET, KURT INGAR
To: AYANDA GROUP AS
Reel/Frame 056685/0842 →
CHANGE OF NAME Recorded Jun 28, 2021
From: AYANDA GROUP AS
To: VITUX GROUP AS
Reel/Frame 056696/0457 →
Priority Claims (1)
GB 0601498 · Jan 25, 2006 · national
Continuity (3)
Continuation 15363372 · Nov 29, 2016
Continuation 12162339
Related Publication 20190290580A1 · Sep 26, 2019